StockData
BeOne Medicines Ltd. logo

BeOne Medicines Ltd. (ONC) income statement

ONCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BEIGF
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 13/302571% above fair value
$403.60−9.66 (-2.34%)

Close on Nov 18, 2026Market cap $45.89BP/E 72.2Yield –

BeOne Medicines Ltd. income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
88.9%
Operating margin
15.1%
Net margin
10.7%
Return on equity, FY2025
7.5%

Financial strength

Current ratio
3.40
Debt to equity
0.22
Debt to assets
12.5%
Cash to current liabilities
240.6%

Valuation

P/E ratio
72.2
Price to sales
7.49
Price to book
8.87
Dividend yield
–

See a number that looks wrong?